BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33656967)

  • 1. Targeted metabolomics as a tool for the diagnosis of kidney disease in Type II diabetes mellitus.
    Abdelsattar S; Kasemy ZA; Elsayed M; Elrahem TA; Zewain SK
    Br J Biomed Sci; 2021 Oct; 78(4):184-190. PubMed ID: 33656967
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomarkers for prognosticating diabetic kidney disease progression.
    Swaminathan SM; Rao IR; Shenoy SV; Prabhu AR; Mohan PB; Rangaswamy D; Bhojaraja MV; Nagri SK; Nagaraju SP
    Int Urol Nephrol; 2023 Apr; 55(4):913-928. PubMed ID: 36271990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normoalbuminuric diabetic kidney disease.
    Chen C; Wang C; Hu C; Han Y; Zhao L; Zhu X; Xiao L; Sun L
    Front Med; 2017 Sep; 11(3):310-318. PubMed ID: 28721497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry.
    Nilavan E; Sundar S; Shenbagamoorthy M; Narayanan H; Nandagopal B; Srinivasan R
    Diabetes Metab Syndr; 2020; 14(6):2073-2078. PubMed ID: 33125920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
    Ibarra-González I; Cruz-Bautista I; Bello-Chavolla OY; Vela-Amieva M; Pallares-Méndez R; Ruiz de Santiago Y Nevarez D; Salas-Tapia MF; Rosas-Flota X; González-Acevedo M; Palacios-Peñaloza A; Morales-Esponda M; Aguilar-Salinas CA; Del Bosque-Plata L
    Acta Diabetol; 2018 Nov; 55(11):1151-1161. PubMed ID: 30173364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus
.
    Pichaiwong W; Homsuwan W; Leelahavanichkul A
    Clin Nephrol; 2019 Aug; 92(2):73-80. PubMed ID: 31198168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
    Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
    Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined detection of urinary biomarkers noninvasively predicts extent of renal injury in patients with early diabetic kidney disease with kidney qi deficiency syndrome: A retrospective investigation.
    Wu W; Meng XJ; Wan BY; Fang QJ; Liu YL; Wang J; Fu Y; Yuan CC; Wang MZ; Chong FL; Wan YG; Shen SM
    Anat Rec (Hoboken); 2023 Dec; 306(12):2945-2957. PubMed ID: 34910381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study.
    Zhang H; Zuo JJ; Dong SS; Lan Y; Wu CW; Mao GY; Zheng C
    J Diabetes Res; 2020; 2020():3049098. PubMed ID: 32190695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.
    Qian F; Zhao L; Zhang D; Yu M; Zhou W; Jin J
    FEBS Open Bio; 2023 Oct; 13(10):1844-1858. PubMed ID: 37525631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes.
    Seidu S; Barrat J; Khunti K
    Prim Care Diabetes; 2020 Aug; 14(4):370-375. PubMed ID: 32139245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of new biomarkers for the diagnosis of nephropathy associated with diabetes type 2.
    Żyłka A; Gala-Błądzińska A; Rybak K; Dumnicka P; Drożdż R; Kuśnierz-Cabala B
    Folia Med Cracov; 2015; 55(4):21-33. PubMed ID: 26867117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
    Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
    Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
    Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
    BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
    Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.